-
1
-
-
0142106750
-
Amyloidosis
-
In: Warrell DA, Cox TM, Firth JD, Benz EJ Jr, editors. 4th ed. Oxford: Oxford University Press
-
Pepys MB, Hawkins PN. Amyloidosis. In: Warrell DA, Cox TM, Firth JD, Benz EJ Jr, editors. Oxford textbook of medicine. 4th ed. Oxford: Oxford University Press; 2003. p. 162-73.
-
(2003)
Oxford Textbook of Medicine
, pp. 162-173
-
-
Pepys, M.B.1
Hawkins, P.N.2
-
3
-
-
0035164775
-
Amyloid precursors and amyloidosis in inflammatory arthritis
-
Cunnane G. Amyloid precursors and amyloidosis in inflammatory arthritis. Curr Opin Rheumatol. 2001;13:67-73.
-
(2001)
Curr Opin Rheumatol.
, vol.13
, pp. 67-73
-
-
Cunnane, G.1
-
4
-
-
4544232356
-
The effect of age, seropositivity and disease duration on autonomic cardiovascular reflexes in patients with rheumatoid arthritis
-
Sandhu V, Allen SC. The effect of age, seropositivity and disease duration on autonomic cardiovascular reflexes in patients with rheumatoid arthritis. Int J Clin Pract. 2004;58:740-5.
-
(2004)
Int J Clin Pract.
, vol.58
, pp. 740-745
-
-
Sandhu, V.1
Allen, S.C.2
-
5
-
-
33746653708
-
Extra-articular manifestations of rheumatoid arthritis: Results of a university hospital of 526 patients in Turkey
-
Calguneri M, Ureten K, Akif Ozturk M, Onat AM, Ertenli I, Kiraz S, et al. Extra-articular manifestations of rheumatoid arthritis: Results of a university hospital of 526 patients in Turkey. Clin Exp Rheumatol. 2006;24:305-8.
-
(2006)
Clin Exp Rheumatol.
, vol.24
, pp. 305-308
-
-
Calguneri, M.1
Ureten, K.2
Akif Ozturk, M.3
Onat, A.M.4
Ertenli, I.5
Kiraz, S.6
-
6
-
-
33748990076
-
The heart and cardiovascular manifestations in rheumatoid arthritis
-
Voskuyl AE. The heart and cardiovascular manifestations in rheumatoid arthritis. Rheumatology. 2006;45:iV4-7.
-
(2006)
Rheumatology
, vol.45
-
-
Voskuyl, A.E.1
-
7
-
-
0033385463
-
Amyloid precursors and amyloidosis in rheumatoid arthritis
-
Cunnane G, Whitehead AS. Amyloid precursors and amyloidosis in rheumatoid arthritis. Bailliere's Clin Rheumatol. 1999;13:615-28.
-
(1999)
Bailliere's Clin Rheumatol.
, vol.13
, pp. 615-628
-
-
Cunnane, G.1
Whitehead, A.S.2
-
8
-
-
0025936525
-
Secondary systemic amyloidosis: Response and survival in 64 patients
-
Gertz MA, Kyle RA. Secondary systemic amyloidosis: Response and survival in 64 patients. Medicine. 1991;70:246-56.
-
(1991)
Medicine
, vol.70
, pp. 246-256
-
-
Gertz, M.A.1
Kyle, R.A.2
-
9
-
-
0033042001
-
Generalized AA-amyloidosis in a 58-year-old Caucasian women with an 18-month history of gastrointestinal tuberculosis
-
Rocken C, Radum D, Glasbrenner B, Malfertheiner P, Roessner A. Generalized AA-amyloidosis in a 58-year-old Caucasian women with an 18-month history of gastrointestinal tuberculosis. Virchows Arch. 1999;434:95-100.
-
(1999)
Virchows Arch.
, vol.434
, pp. 95-100
-
-
Rocken, C.1
Radum, D.2
Glasbrenner, B.3
Malfertheiner, P.4
Roessner, A.5
-
10
-
-
84981220132
-
Combined treatment with cyclophosphamide and prednisolone is effective for secondary amyloidosis with SAA1γ/γ genotype in a patient with rheumatoid arthritis
-
Nakamura T, Baba S, Yamamura Y, Tsuruta T, Matsubara S, Tomoda K, et al. Combined treatment with cyclophosphamide and prednisolone is effective for secondary amyloidosis with SAA1γ/γ genotype in a patient with rheumatoid arthritis. Mod Rheumatol. 2000;10:160-4.
-
(2000)
Mod Rheumatol.
, vol.10
, pp. 160-164
-
-
Nakamura, T.1
Baba, S.2
Yamamura, Y.3
Tsuruta, T.4
Matsubara, S.5
Tomoda, K.6
-
11
-
-
0028011380
-
Serum amyloid A (SAA): Biochemistry, genetics and the pathogenesis of AA amyloidosis
-
Husby G, Marhaug G, Dowton B, Sletten K, Sipe JD. Serum amyloid A (SAA): biochemistry, genetics and the pathogenesis of AA amyloidosis. Amyloid. 1994;1:119-37.
-
(1994)
Amyloid.
, vol.1
, pp. 119-137
-
-
Husby, G.1
Marhaug, G.2
Dowton, B.3
Sletten, K.4
Sipe, J.D.5
-
12
-
-
84959744262
-
The validity of surrogate markers in rheumatic disease
-
Emery P, Luqmani R. The validity of surrogate markers in rheumatic disease. Br J Rheumatol. 1993;32(Suppl 3):3-8.
-
(1993)
Br J Rheumatol.
, vol.32
, Issue.SUPPL. 3
, pp. 3-8
-
-
Emery, P.1
Luqmani, R.2
-
13
-
-
34250003794
-
Natural history and outcome in systemic AA amyloidosis
-
Lachmann HJ, Goodman HJB, Gilbertson JA, Gallimore JR, Sabin CA, Gillmore JD, et al. Natural history and outcome in systemic AA amyloidosis. N Engl J Med. 2007;356:2361-71.
-
(2007)
N Engl J Med.
, vol.356
, pp. 2361-2371
-
-
Lachmann, H.J.1
Goodman, H.J.B.2
Gilbertson, J.A.3
Gallimore, J.R.4
Sabin, C.A.5
Gillmore, J.D.6
-
14
-
-
0036176146
-
Pathology, diagnosis and pathogenesis of AA amyloidosis
-
Rocken C, Shakespeare A. Pathology, diagnosis and pathogenesis of AA amyloidosis. Virchows Arch. 2002;440:111-22.
-
(2002)
Virchows Arch.
, vol.440
, pp. 111-122
-
-
Rocken, C.1
Shakespeare, A.2
-
15
-
-
34548329106
-
Amyloid A amyloidosis secondary to rheumatoid arthritis: An uncommon yet important complication
-
Nakamura T. Amyloid A amyloidosis secondary to rheumatoid arthritis: An uncommon yet important complication. Curr Rheumatol Rev. 2007;3:231-41.
-
(2007)
Curr Rheumatol Rev.
, vol.3
, pp. 231-241
-
-
Nakamura, T.1
-
16
-
-
0027424029
-
Serum amyloid A (SAA): An acute phase protein and apolipoprotein
-
Malle E, Steinmetz A, Raynes JG. Serum amyloid A (SAA): An acute phase protein and apolipoprotein. Atherosclerosis. 1993;102:131-46.
-
(1993)
Atherosclerosis
, vol.102
, pp. 131-146
-
-
Malle, E.1
Steinmetz, A.2
Raynes, J.G.3
-
17
-
-
0033569982
-
Serum amyloid A, the major vertebrate acute-phase reactant
-
Uhlar CM, Whitehead AS. Serum amyloid A, the major vertebrate acute-phase reactant. Eur J Biochem. 1999;265:501-23.
-
(1999)
Eur J Biochem.
, vol.265
, pp. 501-523
-
-
Uhlar, C.M.1
Whitehead, A.S.2
-
18
-
-
0032844668
-
Serum amyloid A1 alleles and plasma concentrations of serum amyloid A
-
Yamada T, Wada A, Itoh Y, Itoh K. Serum amyloid A1 alleles and plasma concentrations of serum amyloid A. Amyloid. 1999;6:199-204.
-
(1999)
Amyloid
, vol.6
, pp. 199-204
-
-
Yamada, T.1
Wada, A.2
Itoh, Y.3
Itoh, K.4
-
19
-
-
0026447176
-
Identification of two novel amyloid A protein subsets coexisting in an individual patient of AA-amyloidosis
-
Baba S, Takahashi T, Kasama T, Shirasawa H. Identification of two novel amyloid A protein subsets coexisting in an individual patient of AA-amyloidosis. Biochim Biophys Acta. 1992;1180:195-200.
-
(1992)
Biochim Biophys Acta
, vol.1180
, pp. 195-200
-
-
Baba, S.1
Takahashi, T.2
Kasama, T.3
Shirasawa, H.4
-
20
-
-
0027191307
-
A novel polymorphism of human serum amyloid A protein, SAA1 gamma, is characterized by alanines at both residues 52 and 57
-
Baba S, Takahashi T, Kasama T, Fujie M, Shirasawa H. A novel polymorphism of human serum amyloid A protein, SAA1 gamma, is characterized by alanines at both residues 52 and 57. Arch Biochem Biophys. 1993;303:361-6.
-
(1993)
Arch Biochem Biophys.
, vol.303
, pp. 361-366
-
-
Baba, S.1
Takahashi, T.2
Kasama, T.3
Fujie, M.4
Shirasawa, H.5
-
21
-
-
29444431739
-
Measurement of serum amyloid A1 (SAA1), a major isotype of acute phase SAA
-
Xu Y, Yamada T, Satoh T, Okuda Y. Measurement of serum amyloid A1 (SAA1), a major isotype of acute phase SAA. Clin Chem Lab Med. 2006;44:59-63.
-
(2006)
Clin Chem Lab Med.
, vol.44
, pp. 59-63
-
-
Xu, Y.1
Yamada, T.2
Satoh, T.3
Okuda, Y.4
-
22
-
-
0029071613
-
A novel allelic variant of serum amyloid A, SAA1γ: Genomic evidence, evolution, frequency, and implication as a risk factor for reactive systemic AA-amyloidosis
-
Baba S, Masago SA, Takahashi T, Kasama T, Sugimura H, Tsugane S, et al. A novel allelic variant of serum amyloid A, SAA1γ: Genomic evidence, evolution, frequency, and implication as a risk factor for reactive systemic AA-amyloidosis. Hum Mol Genet. 1995;4:1083-7.
-
(1995)
Hum Mol Genet.
, vol.4
, pp. 1083-1087
-
-
Baba, S.1
Masago, S.A.2
Takahashi, T.3
Kasama, T.4
Sugimura, H.5
Tsugane, S.6
-
23
-
-
0032855777
-
Influence of genotypes at SAA1 and SAA2 loci on the development and the length of latent period of secondary AA-amyloidosis in patients with rheumatoid arthritis
-
Moriguchi M, Terai C, Koseki Y, Uesato M, Nakajima A, Inada S, et al. Influence of genotypes at SAA1 and SAA2 loci on the development and the length of latent period of secondary AA-amyloidosis in patients with rheumatoid arthritis. Hum Genet. 1999;105:360-6.
-
(1999)
Hum Genet.
, vol.105
, pp. 360-366
-
-
Moriguchi, M.1
Terai, C.2
Koseki, Y.3
Uesato, M.4
Nakajima, A.5
Inada, S.6
-
24
-
-
34250718800
-
SAA1 α/α alleles in Behcet's disease related amyloidosis
-
Utku U, Dilek M, Akpolat I, Bedir A, Akpolat T. SAA1 α/α alleles in Behcet's disease related amyloidosis. Clin Rheumatol. 2007;26:927-9.
-
(2007)
Clin Rheumatol.
, vol.26
, pp. 927-929
-
-
Utku, U.1
Dilek, M.2
Akpolat, I.3
Bedir, A.4
Akpolat, T.5
-
25
-
-
0037367955
-
An allele of serum amyloid A1 associated with amyloidosis in both Japanese and Caucasians
-
Yamada T, Okuda Y, Takasugi K, Wang L, Marks D, Benson MD, et al. An allele of serum amyloid A1 associated with amyloidosis in both Japanese and Caucasians. Amyloid. 2003;10:7-11.
-
(2003)
Amyloid
, vol.10
, pp. 7-11
-
-
Yamada, T.1
Okuda, Y.2
Takasugi, K.3
Wang, L.4
Marks, D.5
Benson, M.D.6
-
26
-
-
21244461521
-
Relative transcriptional activities of SAA1 promoters polymorphic at position -13T(T/C): Potential association between increased transcription and amyloidosis
-
Moriguchi M, Kaneko H, Terai C, Koseki Y, Kajiyama H, Inada S, et al. Relative transcriptional activities of SAA1 promoters polymorphic at position -13T(T/C): Potential association between increased transcription and amyloidosis. Amyloid. 2005;12:26-32.
-
(2005)
Amyloid
, vol.12
, pp. 26-32
-
-
Moriguchi, M.1
Kaneko, H.2
Terai, C.3
Koseki, Y.4
Kajiyama, H.5
Inada, S.6
-
27
-
-
33750075733
-
SAA1 gene polymorphisms and the risk of AA amyloidosis on Japanese patients with rheumatoid arthritis
-
Ajiro J, Narita I, Sato S, Saga D, Hasagawa H, Kuroda T, et al. SAA1 gene polymorphisms and the risk of AA amyloidosis on Japanese patients with rheumatoid arthritis. Mod Rheumatol. 2006;16:294-9.
-
(2006)
Mod Rheumatol.
, vol.16
, pp. 294-299
-
-
Ajiro, J.1
Narita, I.2
Sato, S.3
Saga, D.4
Hasagawa, H.5
Kuroda, T.6
-
28
-
-
0036305051
-
Influence of human leukocyte antigen-DRB1 on the susceptibility and severity of rheumatoid arthritis
-
Gonzalez-Gay MA, Garcia-Porrua C, Hajeer AH. Influence of human leukocyte antigen-DRB1 on the susceptibility and severity of rheumatoid arthritis. Semin Arthritis Rheum. 2002;31:355-60.
-
(2002)
Semin Arthritis Rheum.
, vol.31
, pp. 355-360
-
-
Gonzalez-Gay, M.A.1
Garcia-Porrua, C.2
Hajeer, A.H.3
-
29
-
-
0036743993
-
HLA-DRB1 genotype associations in 793 white patients from a rheumatoid arthritis inception cohort: Frequency, severity, and treatment bias
-
Fries JF, Wolfe F, Apple R, Erlich H, Bugawan T, Holmes T, et al. HLA-DRB1 genotype associations in 793 white patients from a rheumatoid arthritis inception cohort: Frequency, severity, and treatment bias. Arthritis Rheum. 2002;46:2320-9.
-
(2002)
Arthritis Rheum.
, vol.46
, pp. 2320-2329
-
-
Fries, J.F.1
Wolfe, F.2
Apple, R.3
Erlich, H.4
Bugawan, T.5
Holmes, T.6
-
30
-
-
5644264892
-
Genetics of rheumatoid arthritis: Is there a pattern predicting extraarticular manifestations?
-
Turesson C, Weyand CM, Matteson EL. Genetics of rheumatoid arthritis: Is there a pattern predicting extraarticular manifestations? Arthritis Rheum. 2004;51:853-63.
-
(2004)
Arthritis Rheum.
, vol.51
, pp. 853-863
-
-
Turesson, C.1
Weyand, C.M.2
Matteson, E.L.3
-
31
-
-
0031944070
-
An association between the natural course of shoulder joint destruction in rheumatoid arthritis and HLA-DRB1*0405 in Japanese patients
-
Wakitani S, Imoto K, Murata N, Oonishi H, Ochi T, Yoneda M. An association between the natural course of shoulder joint destruction in rheumatoid arthritis and HLA-DRB1*0405 in Japanese patients. Scand J Rheumatol. 1998;27:146-8.
-
(1998)
Scand J Rheumatol.
, vol.27
, pp. 146-148
-
-
Wakitani, S.1
Imoto, K.2
Murata, N.3
Oonishi, H.4
Ochi, T.5
Yoneda, M.6
-
32
-
-
0028907841
-
Correlation between disease phenotype and genetic heterogeneity in rheumatoid arthritis
-
Weyand CM, McCarthy TG, Goronzy JJ. Correlation between disease phenotype and genetic heterogeneity in rheumatoid arthritis. J Clin Invest. 1995;95:2120-6.
-
(1995)
J Clin Invest.
, vol.95
, pp. 2120-2126
-
-
Weyand, C.M.1
McCarthy, T.G.2
Goronzy, J.J.3
-
33
-
-
33750975085
-
HLA-DRB1*04 alleles in Japanese rheumatoid arthritis patients with AA amyloidosis
-
Migita K, Nakamura T, Maeda Y, Miyashita T, Origuchi T, Yatsuhashi H, et al. HLA-DRB1*04 alleles in Japanese rheumatoid arthritis patients with AA amyloidosis. J Rheumatol. 2006;33:2120-3.
-
(2006)
J Rheumatol.
, vol.33
, pp. 2120-2123
-
-
Migita, K.1
Nakamura, T.2
Maeda, Y.3
Miyashita, T.4
Origuchi, T.5
Yatsuhashi, H.6
-
35
-
-
41849114209
-
Effect of SAA1.3 allele genotype on clinical course in Japanese amyloidotic patients secondary to rheumatoid arthritis
-
Nakamura T, Tsukano M, Tomoda K, Yamamura Y, Shono M, Baba S. Effect of SAA1.3 allele genotype on clinical course in Japanese amyloidotic patients secondary to rheumatoid arthritis. Arthritis Rheum. 2004;50(Suppl):163.
-
(2004)
Arthritis Rheum.
, vol.50
, Issue.SUPPL.
, pp. 163
-
-
Nakamura, T.1
Tsukano, M.2
Tomoda, K.3
Yamamura, Y.4
Shono, M.5
Baba, S.6
-
36
-
-
34548312539
-
Novel polymorphisms in the 5′-flanking region of the human serum amyloid A1 (SAA1) gene and an association with reactive AA-amyloidosis
-
Baba S, Nakai H, Nakamura T, Miyamoto S, Ohta Y, Takahashi T, et al. Novel polymorphisms in the 5′-flanking region of the human serum amyloid A1 (SAA1) gene and an association with reactive AA-amyloidosis. Amyloid. 2001;8(Suppl 2):41-3.
-
(2001)
Amyloid
, vol.8
, Issue.SUPPL. 2
, pp. 41-43
-
-
Baba, S.1
Nakai, H.2
Nakamura, T.3
Miyamoto, S.4
Ohta, Y.5
Takahashi, T.6
-
37
-
-
29844441293
-
Significance of SAA1.3 allele genotype in Japanese patients with amyloidosis secondary to rheumatoid arthritis
-
Nakamura T, Higashi S, Tomoda K, Tsukano M, Baba S, Shono M. Significance of SAA1.3 allele genotype in Japanese patients with amyloidosis secondary to rheumatoid arthritis. Rheumatology. 2006;45:43-9.
-
(2006)
Rheumatology
, vol.45
, pp. 43-49
-
-
Nakamura, T.1
Higashi, S.2
Tomoda, K.3
Tsukano, M.4
Baba, S.5
Shono, M.6
-
38
-
-
0023223933
-
Secondary amyloidosis of the bladder: A cause of massive hematuria
-
Nurumi MJ, Ekfors TO, Puntala PV. Secondary amyloidosis of the bladder: a cause of massive hematuria. J Urol. 1987;138:44-5.
-
(1987)
J Urol.
, vol.138
, pp. 44-45
-
-
Nurumi, M.J.1
Ekfors, T.O.2
Puntala, P.V.3
-
39
-
-
0141884210
-
Massive hematuria due to bladder amyloidosis in patients with rheumatoid arthritis: Three case reports
-
Nakamura T, Yamamura Y, Tomoda K, Tsukano M, Baba S. Massive hematuria due to bladder amyloidosis in patients with rheumatoid arthritis: Three case reports. Clin Exp Rheumatol. 2003;21:673-4.
-
(2003)
Clin Exp Rheumatol.
, vol.21
, pp. 673-674
-
-
Nakamura, T.1
Yamamura, Y.2
Tomoda, K.3
Tsukano, M.4
Baba, S.5
-
40
-
-
0035147048
-
The clinical significance of amyloid fat deposit in rheumatoid arthritis. A systemic long-term followup study using abdominal fat aspiration
-
Gomez-Casanovas E, Sanmarti R, Sole M, Canate JD, Munoz-Gomez J. The clinical significance of amyloid fat deposit in rheumatoid arthritis. A systemic long-term followup study using abdominal fat aspiration. Arthritis Rheum. 2001;44:66-72.
-
(2001)
Arthritis Rheum.
, vol.44
, pp. 66-72
-
-
Gomez-Casanovas, E.1
Sanmarti, R.2
Sole, M.3
Canate, J.D.4
Munoz-Gomez, J.5
-
41
-
-
0028084977
-
Cause of death in 81 autopsied patients with rheumatoid arthritis
-
Suzuki A, Ohosone Y, Obana M, Mita S, Matsuoka Y, Irimajiri S, et al. Cause of death in 81 autopsied patients with rheumatoid arthritis. J Rheumatol. 1994;21:33-6.
-
(1994)
J Rheumatol.
, vol.21
, pp. 33-36
-
-
Suzuki, A.1
Ohosone, Y.2
Obana, M.3
Mita, S.4
Matsuoka, Y.5
Irimajiri, S.6
-
42
-
-
0141892843
-
Abdominal fat aspiration biopsy and genotyping of serum amyloid A contribute to early diagnosis of reactive AA amyloidosis secondary to rheumatoid arthritis
-
Ishii W, Matsuda M, Nakamura A, Nakamura N, Suzuki A, Ikeda S. Abdominal fat aspiration biopsy and genotyping of serum amyloid A contribute to early diagnosis of reactive AA amyloidosis secondary to rheumatoid arthritis. Intern Med. 2003;42:800-5.
-
(2003)
Intern Med.
, vol.42
, pp. 800-805
-
-
Ishii, W.1
Matsuda, M.2
Nakamura, A.3
Nakamura, N.4
Suzuki, A.5
Ikeda, S.6
-
43
-
-
0038076261
-
Prevalence of secondary amyloidosis in Asian north Indian patients with rheumatoid arthritis
-
Wakhlu A, Krisnani N, Hissatia P, Aggarwal A, Misra R. Prevalence of secondary amyloidosis in Asian north Indian patients with rheumatoid arthritis. J Rheumatol. 2003;30:948-51.
-
(2003)
J Rheumatol.
, vol.30
, pp. 948-951
-
-
Wakhlu, A.1
Krisnani, N.2
Hissatia, P.3
Aggarwal, A.4
Misra, R.5
-
44
-
-
0036147031
-
Screening for amyloid in subcutaneous fat tissue of Egyptian patients with rheumatoid arthritis: Clinical and laboratory characteristics
-
El Mansoury TM, Hazenberg BP, El Badawy SA, Ahmed AH, Bijzet J, Limburg PC, et al. Screening for amyloid in subcutaneous fat tissue of Egyptian patients with rheumatoid arthritis: Clinical and laboratory characteristics. Ann Rheum Dis. 2002;61:42-7.
-
(2002)
Ann Rheum Dis.
, vol.61
, pp. 42-47
-
-
El Mansoury, T.M.1
Hazenberg, B.P.2
El Badawy, S.A.3
Ahmed, A.H.4
Bijzet, J.5
Limburg, P.C.6
-
45
-
-
1542681892
-
Secondary amyloidosis in patients with rheumatoid arthritis: Diagnostic and prognostic value of gastroduodenal biopsy
-
Kobayashi H, Tada S, Fuchigami T, Okuda Y, Takasugi K, Miyamoto T, et al. Secondary amyloidosis in patients with rheumatoid arthritis: diagnostic and prognostic value of gastroduodenal biopsy. Br J Rheumatol. 1996;35:44-9.
-
(1996)
Br J Rheumatol.
, vol.35
, pp. 44-49
-
-
Kobayashi, H.1
Tada, S.2
Fuchigami, T.3
Okuda, Y.4
Takasugi, K.5
Miyamoto, T.6
-
46
-
-
0042887249
-
Rheumatoid arthritis in Spain: Occurrence of extra-articular manifestations and estimates of disease severity
-
Carmona L, Gonzalez-Alvaro I, Balsa A, Belmonte MA, Tena X, Sanmarti R. Rheumatoid arthritis in Spain: Occurrence of extra-articular manifestations and estimates of disease severity. Ann Rheum Dis. 2003;62:897-900.
-
(2003)
Ann Rheum Dis.
, vol.62
, pp. 897-900
-
-
Carmona, L.1
Gonzalez-Alvaro, I.2
Balsa, A.3
Belmonte, M.A.4
Tena, X.5
Sanmarti, R.6
-
47
-
-
0037385944
-
Patterns of disease modifying antirheumatic drug use in a Spanish cohort of patients with rheumatoid arthritis
-
Gonzalez-Alvaro I, Carmona L, Balsa A, Sanmarti R, Belmonte MA, Tena X. Patterns of disease modifying antirheumatic drug use in a Spanish cohort of patients with rheumatoid arthritis. J Rheumatol. 2003;30:697-704.
-
(2003)
J Rheumatol.
, vol.30
, pp. 697-704
-
-
Gonzalez-Alvaro, I.1
Carmona, L.2
Balsa, A.3
Sanmarti, R.4
Belmonte, M.A.5
Tena, X.6
-
48
-
-
34548297952
-
Prevalence of silent amyloidosis in rheumatoid arthritis and its clinical significance
-
Misra R, Wakhlu A, Krishnani N, Hissaaria P, Aggarwal A. Prevalence of silent amyloidosis in rheumatoid arthritis and its clinical significance. J Rheumatol. 2004;31:1031-4.
-
(2004)
J Rheumatol.
, vol.31
, pp. 1031-1034
-
-
Misra, R.1
Wakhlu, A.2
Krishnani, N.3
Hissaaria, P.4
Aggarwal, A.5
-
49
-
-
0033895284
-
Presentation, survival and prognostic markers in AA amyloidosis
-
Joss N, McLaughlin K, Simpson K, Boulton-Jones JM. Presentation, survival and prognostic markers in AA amyloidosis. Q J Med. 2000;93:535-42.
-
(2000)
Q J Med.
, vol.93
, pp. 535-542
-
-
Joss, N.1
McLaughlin, K.2
Simpson, K.3
Boulton-Jones, J.M.4
-
50
-
-
0038209794
-
Clinical outcome and survival of secondary (AA) amyloidosis
-
Tanaka F, Migita K, Honda S, Fukuda T, Mine M, Nakamura T, et al. Clinical outcome and survival of secondary (AA) amyloidosis. Clin Exp Rheumatol. 2003;21:343-6.
-
(2003)
Clin Exp Rheumatol.
, vol.21
, pp. 343-346
-
-
Tanaka, F.1
Migita, K.2
Honda, S.3
Fukuda, T.4
Mine, M.5
Nakamura, T.6
-
51
-
-
0036311992
-
Clinical and biochemical outcome of renal amyloidosis
-
Odabas AR, Cetinkaya R, Selcuk Y, Erman Z, Bilen H. Clinical and biochemical outcome of renal amyloidosis. Int J Clin Pract. 2002;56:342-4.
-
(2002)
Int J Clin Pract.
, vol.56
, pp. 342-344
-
-
Odabas, A.R.1
Cetinkaya, R.2
Selcuk, Y.3
Erman, Z.4
Bilen, H.5
-
52
-
-
0035822274
-
Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein
-
Gillmore JO, Levitt LB, Jersey MA, PepysMB, Hawkins PN. Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein. Lancet. 2001;358:24-9.
-
(2001)
Lancet
, vol.358
, pp. 24-29
-
-
Gillmore, J.O.1
Levitt, L.B.2
Jersey, M.A.3
Pepys, M.B.4
Hawkins, P.N.5
-
53
-
-
41849122335
-
Female is a risk factor for developing AA-amyloidosis in patients with rheumatoid arthritis
-
Kitahama M, Koseki Y, Sakurai T, Kamatani N, Terai C. Female is a risk factor for developing AA-amyloidosis in patients with rheumatoid arthritis. Arthritis Rheum. 2007;56(Suppl):410-1.
-
(2007)
Arthritis Rheum.
, vol.56
, Issue.SUPPL.
, pp. 410-411
-
-
Kitahama, M.1
Koseki, Y.2
Sakurai, T.3
Kamatani, N.4
Terai, C.5
-
54
-
-
0022870564
-
Severe autonomic neuropathy in amyloidosis secondary to rheumatoid arthritis
-
McGill NW, Tuck R, Hassall JE. Severe autonomic neuropathy in amyloidosis secondary to rheumatoid arthritis. Aust N Z J Med. 1986;16:705-7.
-
(1986)
Aust N Z J Med.
, vol.16
, pp. 705-707
-
-
McGill, N.W.1
Tuck, R.2
Hassall, J.E.3
-
55
-
-
11144316233
-
Gustatory sweating due to autonomic neuropathy in a patient with amyloidosis secondary to rheumatoid arthritis
-
Nakamura T, Tomoda K, Tsukano M, Yamamura Y, Baba S. Gustatory sweating due to autonomic neuropathy in a patient with amyloidosis secondary to rheumatoid arthritis. Mod Rheumatol. 2004;14:498-501.
-
(2004)
Mod Rheumatol.
, vol.14
, pp. 498-501
-
-
Nakamura, T.1
Tomoda, K.2
Tsukano, M.3
Yamamura, Y.4
Baba, S.5
-
56
-
-
0344406267
-
Cytostatic therapy for AA amyloidosis complicating psoriatic spondyloarthropathy
-
Mpofu S, Teh LS, Smith PJ, Moots RJ, Hawkins PN. Cytostatic therapy for AA amyloidosis complicating psoriatic spondyloarthropathy. Rheumatology. 2003;42:362-6.
-
(2003)
Rheumatology
, vol.42
, pp. 362-366
-
-
Mpofu, S.1
Teh, L.S.2
Smith, P.J.3
Moots, R.J.4
Hawkins, P.N.5
-
57
-
-
0036166309
-
How to diagnose rheumatoid arthritis early. A prediction model for persistent (erosive) arthritis
-
Visser H, le Cessie S, Vos K, Breedveld FC, Hazes JMW. How to diagnose rheumatoid arthritis early. A prediction model for persistent (erosive) arthritis. Arthritis Rheum. 2002;46:357-65.
-
(2002)
Arthritis Rheum.
, vol.46
, pp. 357-365
-
-
Visser, H.1
le Cessie, S.2
Vos, K.3
Breedveld, F.C.4
Hazes, J.M.W.5
-
58
-
-
20244384856
-
Amyloidosis and auto-inflammatory syndromes
-
Grateau G, Jeru I, Rouaghe S, Cazeneuve C, Ravet N, Duquesnoy P, et al. Amyloidosis and auto-inflammatory syndromes. Curr Drug Targets Inflamm Allergy. 2005;4:57-65.
-
(2005)
Curr Drug Targets Inflamm Allergy
, vol.4
, pp. 57-65
-
-
Grateau, G.1
Jeru, I.2
Rouaghe, S.3
Cazeneuve, C.4
Ravet, N.5
Duquesnoy, P.6
-
59
-
-
0038174742
-
Phenol Congo red staining enhances the diagnostic value of abdominal fat aspiration biopsy in reactive AA amyloidosis secondary to rheumatoid arthritis
-
Ishii W, Matsuda M, Nakamura N, Katsumata S, Toriumi H, Suzuki A, et al. Phenol Congo red staining enhances the diagnostic value of abdominal fat aspiration biopsy in reactive AA amyloidosis secondary to rheumatoid arthritis. Intern Med. 2003;42:400-5.
-
(2003)
Intern Med.
, vol.42
, pp. 400-405
-
-
Ishii, W.1
Matsuda, M.2
Nakamura, N.3
Katsumata, S.4
Toriumi, H.5
Suzuki, A.6
-
60
-
-
11144354315
-
Sustained improvement over two years in physical function, structural damage, and signs and symptoms among patients with rheumatoid arthritis treated with infliximab and methotrexate
-
Maini RN, Breedveld FC, Kalden JR, Smolen JS, Furst D, Weisman MH, et al. Sustained improvement over two years in physical function, structural damage, and signs and symptoms among patients with rheumatoid arthritis treated with infliximab and methotrexate. Arthritis Rheum. 2004;50:1051-65.
-
(2004)
Arthritis Rheum.
, vol.50
, pp. 1051-1065
-
-
Maini, R.N.1
Breedveld, F.C.2
Kalden, J.R.3
Smolen, J.S.4
Furst, D.5
Weisman, M.H.6
-
61
-
-
0142093231
-
Window of opportunity in early rheumatoid arthritis: Possibility of altering the disease process with early intervention
-
Quinn MA, Emery P. Window of opportunity in early rheumatoid arthritis: possibility of altering the disease process with early intervention. Clin Exp Rheumatol. 2003;21(Suppl 31):154-64.
-
(2003)
Clin Exp Rheumatol.
, vol.21
, Issue.SUPPL. 31
, pp. 154-164
-
-
Quinn, M.A.1
Emery, P.2
-
62
-
-
0023597242
-
Cytotoxic drug treatment of reactive amyloidosis in rheumatoid arthritis with special reference to renal insufficiency
-
Ahlmen M, Ahlmen J, Svalander C, Bucht H. Cytotoxic drug treatment of reactive amyloidosis in rheumatoid arthritis with special reference to renal insufficiency. Clin Rheumatol. 1987;6:27-38.
-
(1987)
Clin Rheumatol.
, vol.6
, pp. 27-38
-
-
Ahlmen, M.1
Ahlmen, J.2
Svalander, C.3
Bucht, H.4
-
63
-
-
0027715981
-
Results, principles and pitfalls in the management of renal AA-amyloidosis: A 10-21 year followup of 16 patients with rheumatic disease treated with alkylating cytostatics
-
Berglund K, Thysell H, Keller C. Results, principles and pitfalls in the management of renal AA-amyloidosis: A 10-21 year followup of 16 patients with rheumatic disease treated with alkylating cytostatics. J Rheumatol. 1993;20:2051-7.
-
(1993)
J Rheumatol.
, vol.20
, pp. 2051-2057
-
-
Berglund, K.1
Thysell, H.2
Keller, C.3
-
64
-
-
0034894409
-
Renal type AA amyloidosis associated with rheumatoid arthritis: A cohort study showing improved survival on treatment with pulse cyclophosphamide
-
Chevrel G, Jenvrin C, McGregor B, Miossec P. Renal type AA amyloidosis associated with rheumatoid arthritis: A cohort study showing improved survival on treatment with pulse cyclophosphamide. Rheumatology. 2001;40:821-5.
-
(2001)
Rheumatology
, vol.40
, pp. 821-825
-
-
Chevrel, G.1
Jenvrin, C.2
McGregor, B.3
Miossec, P.4
-
65
-
-
0029591203
-
Regression of the nephrotic syndrome in rheumatoid arthritis and amyloidosis treated with azathioprine. A case report
-
Shapiro DL, Spiera H. Regression of the nephrotic syndrome in rheumatoid arthritis and amyloidosis treated with azathioprine. A case report. Arthritis Rheum. 1995;38:1851-4.
-
(1995)
Arthritis Rheum.
, vol.38
, pp. 1851-1854
-
-
Shapiro, D.L.1
Spiera, H.2
-
66
-
-
0029037389
-
Methotrexate treatment of amyloidosis secondary to rheumatoid arthritis
-
Fiter J, Nolla JM, Valverde J, Roig ED. Methotrexate treatment of amyloidosis secondary to rheumatoid arthritis. Rev Clin Esp. 1995;195:390-2.
-
(1995)
Rev Clin Esp.
, vol.195
, pp. 390-392
-
-
Fiter, J.1
Nolla, J.M.2
Valverde, J.3
Roig, E.D.4
-
67
-
-
2342511644
-
Efficacy of cyclophosphamide combined with prednisolone in patients with AA amyloidosis secondary to rheumatoid arthritis
-
Nakamura T, Yamamura Y, Tomoda K, Tsukano M, Shono M, Baba S. Efficacy of cyclophosphamide combined with prednisolone in patients with AA amyloidosis secondary to rheumatoid arthritis. Clin Rheumatol. 2003;22:371-5.
-
(2003)
Clin Rheumatol.
, vol.22
, pp. 371-375
-
-
Nakamura, T.1
Yamamura, Y.2
Tomoda, K.3
Tsukano, M.4
Shono, M.5
Baba, S.6
-
68
-
-
34249992082
-
Eprodisate for the treatment of renal disease in AA amyloidosis
-
Dember LM, Hawkins PN, Hanzenberg BPC, Gorevic PD, Merlini GM, Butrimiene I, et al. Eprodisate for the treatment of renal disease in AA amyloidosis. N Engl J Med. 2007;356:2349-60.
-
(2007)
N Engl J Med.
, vol.356
, pp. 2349-2360
-
-
Dember, L.M.1
Hawkins, P.N.2
Hanzenberg, B.P.C.3
Gorevic, P.D.4
Merlini, G.M.5
Butrimiene, I.6
-
69
-
-
41849110594
-
Treatment with eprodisate results in a significant delay in the progression to dialysis/end-stage renal disease in amyloid A amyloidosis patients: Analysis including retrieved follow-up data
-
Gorevic PD, Hawkins PN, Skinner M, Nasonov EL, Butrimiene I, Benson MD, et al. Treatment with eprodisate results in a significant delay in the progression to dialysis/end-stage renal disease in amyloid A amyloidosis patients: Analysis including retrieved follow-up data. Arthritis Rheum. 2007;56(Suppl):520.
-
(2007)
Arthritis Rheum.
, vol.56
, Issue.SUPPL.
, pp. 520
-
-
Gorevic, P.D.1
Hawkins, P.N.2
Skinner, M.3
Nasonov, E.L.4
Butrimiene, I.5
Benson, M.D.6
-
70
-
-
0034735842
-
Infliximab and methotrexate in the treatment of rheumatoid arthritis
-
Lipsky PE, van der Heijde DMFM, St Clair EW, Furst DE, Breedveld FC, Kalden JR, et al. Infliximab and methotrexate in the treatment of rheumatoid arthritis. N Engl J Med. 2000;343:1594-602.
-
(2000)
N Engl J Med.
, vol.343
, pp. 1594-1602
-
-
Lipsky, P.E.1
van der Heijde, D.M.F.M.2
St Clair, E.W.3
Furst, D.E.4
Breedveld, F.C.5
Kalden, J.R.6
-
71
-
-
10744223002
-
Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: Double-blind randomized controlled trial
-
Klareskog L, van der Heiji D, de Jager JP, Gough A, Kalden J, Malaise M, et al. Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: Double-blind randomized controlled trial. Lancet. 2004;363:675-81.
-
(2004)
Lancet
, vol.363
, pp. 675-681
-
-
Klareskog, L.1
van der Heiji, D.2
de Jager, J.P.3
Gough, A.4
Kalden, J.5
Malaise, M.6
-
72
-
-
8344222831
-
Etanercept treatment of renal amyloidosis complicating rheumatoid arthritis
-
Smith GR, Tymmus KE, Falk M. Etanercept treatment of renal amyloidosis complicating rheumatoid arthritis. Intern Med J. 2004;34:570-2.
-
(2004)
Intern Med J.
, vol.34
, pp. 570-572
-
-
Smith, G.R.1
Tymmus, K.E.2
Falk, M.3
-
73
-
-
0036822905
-
Rapid and complete resolution of proteinuria due to renal amyloidosis in a patient with rheumatoid arthritis treated with infliximab
-
Elkayam O, Hawkins PN, Lachmann H, Yaron M, Caspi D. Rapid and complete resolution of proteinuria due to renal amyloidosis in a patient with rheumatoid arthritis treated with infliximab. Arthritis Rheum. 2002;46:2571-3.
-
(2002)
Arthritis Rheum.
, vol.46
, pp. 2571-5273
-
-
Elkayam, O.1
Hawkins, P.N.2
Lachmann, H.3
Yaron, M.4
Caspi, D.5
-
75
-
-
0037666987
-
Anti-tumor necrosis factor α therapy in fifteen patients with AA amyloidosis secondary to inflammatory arthritides. A followup report of tolerability and efficacy
-
Gottenberg J-E, Merle-Vincent F, Bentaberry F, Allanore Y, Berenbaum F, Fautrel B, et al. Anti-tumor necrosis factor α therapy in fifteen patients with AA amyloidosis secondary to inflammatory arthritides. A followup report of tolerability and efficacy. Arthritis Rheum. 2003;48:2019-24.
-
(2003)
Arthritis Rheum.
, vol.48
, pp. 2019-2024
-
-
Gottenberg, J.-E.1
Merle-Vincent, F.2
Bentaberry, F.3
Allanore, Y.4
Berenbaum, F.5
Fautrel, B.6
-
76
-
-
2442432420
-
Case report: Response in proteinuria due to AA amyloidosis but not Felty's syndrome in a patient with rheumatoid arthritis treated with TNF-α blockade
-
Ravindran J, Shenker N, Bhalla AK, Lachmann H, Hawkins P. Case report: response in proteinuria due to AA amyloidosis but not Felty's syndrome in a patient with rheumatoid arthritis treated with TNF-α blockade. Rheumatology. 2004;43:669-72.
-
(2004)
Rheumatology
, vol.43
, pp. 669-672
-
-
Ravindran, J.1
Shenker, N.2
Bhalla, A.K.3
Lachmann, H.4
Hawkins, P.5
-
77
-
-
20944451093
-
Treatment of rheumatic inflammatory disease in 25 patients with secondary amyloidosis using tumor necrosis factor alpha antagonists
-
Fernandes-Nebro A, Tomero E, Ortiz-Santamaria V, Castro MC, Olive A, de Haro M, et al. Treatment of rheumatic inflammatory disease in 25 patients with secondary amyloidosis using tumor necrosis factor alpha antagonists. Am J Med. 2005;118:552-6.
-
(2005)
Am J Med.
, vol.118
, pp. 552-556
-
-
Fernandes-Nebro, A.1
Tomero, E.2
Ortiz-Santamaria, V.3
Castro, M.C.4
Olive, A.5
de Haro, M.6
-
78
-
-
33749331603
-
Successful use of a humanized anti-interleukin-6 receptor antibody, tocilizmab, to treat amyloid A amyloidosis complicating juvenile idiopathic arthritis
-
Okuda Y, Takasugi K. Successful use of a humanized anti-interleukin-6 receptor antibody, tocilizmab, to treat amyloid A amyloidosis complicating juvenile idiopathic arthritis. Arthritis Rheum. 2006;54:2997-3000.
-
(2006)
Arthritis Rheum.
, vol.54
, pp. 2997-3000
-
-
Okuda, Y.1
Takasugi, K.2
-
79
-
-
34648846150
-
Efficacy of etanercept in patients with AA amyloidosis secondary to rheumatoid arthritis
-
Nakamura T, Higashi S, Tomoda K, Tsukano M, Baba S. Efficacy of etanercept in patients with AA amyloidosis secondary to rheumatoid arthritis. Clin Exp Rheumatol. 2007;25:518-22.
-
(2007)
Clin Exp Rheumatol.
, vol.25
, pp. 518-522
-
-
Nakamura, T.1
Higashi, S.2
Tomoda, K.3
Tsukano, M.4
Baba, S.5
-
80
-
-
0033819386
-
Successful treatment of protein-losing enteropathy due to AA amyloidosis with somatostatin analogue and high dose steroid in ankylosing spondylitis
-
Jeong Y-S, Jun J-B, Kim T-H, Lee I-H, Bae S-C, Yoo D-H, et al. Successful treatment of protein-losing enteropathy due to AA amyloidosis with somatostatin analogue and high dose steroid in ankylosing spondylitis. Clin Exp Rheumatol. 2000;18:619-21.
-
(2000)
Clin Exp Rheumatol.
, vol.18
, pp. 619-621
-
-
Jeong, Y.-S.1
Jun, J.-B.2
Kim, T.-H.3
Lee, I.-H.4
Bae, S.-C.5
Yoo, D.-H.6
-
81
-
-
21244476771
-
Severe protein losing enteropathy with intractable diarrhea due to systemic AA amyloidosis, successfully treated with corticosteroid and octreotide
-
Fushimi T, Takahashi Y, Kashima Y, Fukushima K, Ishii W, Kaneko K, et al. Severe protein losing enteropathy with intractable diarrhea due to systemic AA amyloidosis, successfully treated with corticosteroid and octreotide. Amyloid. 2005;12:48-53.
-
(2005)
Amyloid
, vol.12
, pp. 48-53
-
-
Fushimi, T.1
Takahashi, Y.2
Kashima, Y.3
Fukushima, K.4
Ishii, W.5
Kaneko, K.6
-
82
-
-
0032960338
-
Secondary amyloidosis has decreased in patients with inflammatory joint disease in Finland
-
Laiho K, Tiitinen S, Kaarela K, Helin H, Isomaki H. Secondary amyloidosis has decreased in patients with inflammatory joint disease in Finland. Clin Rheumatol. 1999;18:122-3.
-
(1999)
Clin Rheumatol.
, vol.18
, pp. 122-123
-
-
Laiho, K.1
Tiitinen, S.2
Kaarela, K.3
Helin, H.4
Isomaki, H.5
-
85
-
-
0036169930
-
Guidelines for the management of rheumatoid arthritis: 2002 Update
-
American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines
-
American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines. Guidelines for the management of rheumatoid arthritis: 2002 Update. Arthritis Rheum. 2002;46:328-46.
-
(2002)
Arthritis Rheum.
, vol.46
, pp. 328-346
-
-
-
86
-
-
0345299157
-
Amyloid protein SAA is associated with high density lipoprotein from human serum
-
Benditt EP, Eriksen N. Amyloid protein SAA is associated with high density lipoprotein from human serum. Proc Natl Acad Sci (USA) 1977;74:4025-8.
-
(1977)
Proc Natl Acad Sci (USA)
, vol.74
, pp. 4025-4028
-
-
Benditt, E.P.1
Eriksen, N.2
-
87
-
-
0029049806
-
Serum amyloid A (SAA): Influence on HDL-mediated cellular cholesterol efflux
-
Banka CL, Yuan T, de Beer MC, Kindy M, Curtiss LK, de Beer FC. Serum amyloid A (SAA): Influence on HDL-mediated cellular cholesterol efflux. J Lipid Res. 1995;36:1058-65.
-
(1995)
J Lipid Res.
, vol.36
, pp. 1058-1065
-
-
Banka, C.L.1
Yuan, T.2
de Beer, M.C.3
Kindy, M.4
Curtiss, L.K.5
de Beer, F.C.6
-
88
-
-
0034687430
-
Inflammatory markers of coronary risk
-
Rader DJ. Inflammatory markers of coronary risk. N Engl J Med. 2000;343:1179-82.
-
(2000)
N Engl J Med.
, vol.343
, pp. 1179-1182
-
-
Rader, D.J.1
-
89
-
-
33646417915
-
Serum amyloid A. The "other" inflammatory protein
-
O'Brein KD, Chait A. Serum amyloid A. The "other" inflammatory protein. Curr Atheroscler Rep. 2006;8:62-8.
-
(2006)
Curr Atheroscler Rep.
, vol.8
, pp. 62-68
-
-
O'Brein, K.D.1
Chait, A.2
-
90
-
-
34250872848
-
Impact of serum amyloid A on tissue factor and tissue factor pathway inhibitor expression and activity in endothelial cells
-
Zhao Y, Zhou S, Heng C-K. Impact of serum amyloid A on tissue factor and tissue factor pathway inhibitor expression and activity in endothelial cells. Thromb Vasc Biol. 2007;27:1645-50.
-
(2007)
Thromb Vasc Biol.
, vol.27
, pp. 1645-1650
-
-
Zhao, Y.1
Zhou, S.2
Heng, C.-K.3
-
91
-
-
34250197588
-
Cystatin C binds serum amyloid A, downregulating its cytokine-generating properties
-
Bokarewa M, Abrahamson M, Levshin N, Egesten A, Grubb A, Dahlberg L, et al. Cystatin C binds serum amyloid A, downregulating its cytokine-generating properties. J Rheumatol. 2007;34:1293-301.
-
(2007)
J Rheumatol.
, vol.34
, pp. 1293-1301
-
-
Bokarewa, M.1
Abrahamson, M.2
Levshin, N.3
Egesten, A.4
Grubb, A.5
Dahlberg, L.6
-
92
-
-
33749529307
-
Serum amyloid A binding to formyl peptide receptor-like 1 induces synovial hyperplasia and angiogenesis
-
Lee M-S, Yoo S-A, Cho C-S, Suh P-G, Kim W-U, Ryu SH. Serum amyloid A binding to formyl peptide receptor-like 1 induces synovial hyperplasia and angiogenesis. J Immunol. 2006;177:5585-94.
-
(2006)
J Immunol.
, vol.177
, pp. 5585-5594
-
-
Lee, M.-S.1
Yoo, S.-A.2
Cho, C.-S.3
Suh, P.-G.4
Kim, W.-U.5
Ryu, S.H.6
|